Cited by

• DBI (diazepam binding inhibitor): the precursor of a family of endogenous modulators of GABAA receptor function. History, perspectives, and clinical implications.

  Barbaccia ML, Berkovich A, Guarneri P, Slobodyansky E. Barbaccia ML, et al. Neurochem Res. 1990 Feb;15(2):161-8. doi: 10.1007/BF00972206. Neurochem Res. 1990. PMID: 2159121 Review.
• Enhanced GABA release in cerebral cortical slices derived from rats with thioacetamide-induced hepatic encephalopathy.

  Wysmyk U, Oja SS, Saransaari P, Albrecht J. Wysmyk U, et al. Neurochem Res. 1992 Dec;17(12):1187-90. doi: 10.1007/BF00968397. Neurochem Res. 1992. PMID: 1461366
• Flumazenil does not improve hepatic encephalopathy associated with acute ischemic liver failure in the rabbit.

  van der Rijt CC, de Knegt RJ, Schalm SW, Terpstra OT, Mechelse K. van der Rijt CC, et al. Metab Brain Dis. 1990 Sep;5(3):131-41. doi: 10.1007/BF00999840. Metab Brain Dis. 1990. PMID: 2273999
• Flumazenil in the treatment of portal systemic encephalopathy--an overview.

  Gyr K, Meier R. Gyr K, et al. Intensive Care Med. 1991;17 Suppl 1:S39-42. doi: 10.1007/BF01731153. Intensive Care Med. 1991. PMID: 1774410 Review.
• Brain concentrations of benzodiazepines are elevated in an animal model of hepatic encephalopathy.

  Basile AS, Pannell L, Jaouni T, Gammal SH, Fales HM, Jones EA, Skolnick P. Basile AS, et al. Proc Natl Acad Sci U S A. 1990 Jul;87(14):5263-7. doi: 10.1073/pnas.87.14.5263. Proc Natl Acad Sci U S A. 1990. PMID: 1973539 Free PMC article.